This suggests that concomitantly ARID1A negative staining and ß-Catenin nuclear and membrane/cytoplasm positive (n+m+) staining respectively ß-Catenin nuclear and membrane negative staining (n-m-) might play a role in tumor progression in type I endometrial cancer. Here, ARID1A is linked to endometrial cancer.